GlassScriptPhysician profile
Eric Ricardo Haynes
NPI 1982671954
$10,442.62
in general payments reported to CMS, 2019-2025
44 companies · $991 in 2025
The $991 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $834 · 2020: $650 · 2021: $1,041 · 2022: $858 · 2023: $2,185 · 2024: $3,884 · 2025: $991.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,876 · Travel and Lodging: $3,168 · Gift: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,876.08 |
| Travel and Lodging | $3,167.98 |
| Gift | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,961.94 | 2019-2025 | Wavewriter Alpha Prime 16, G4 Rf Generator, Infinion 16 |
| Genesys Orthopedics Systems, L.L.C. | $1,293.12 | 2023 | Sacroiliac Joint Fusion System |
| Si-Bone, INC. | $1,075.10 | 2024-2025 | |
| Abbvie INC. | $891.30 | 2021-2025 | |
| Collegium Pharmaceutical, INC. | $731.05 | 2019-2025 | Xtampza, Belbuca |
| Indivior INC. | $523.79 | 2019-2025 | Sublocade |
| Pfizer INC. | $479.76 | 2019-2025 | |
| Scilex Pharmaceuticals INC. | $451.25 | 2019-2025 | Ztlido |
| Novartis Pharmaceuticals Corporation | $183.78 | 2019-2021 | |
| Daiichi Sankyo INC. | $170.28 | 2019 | |
| Acacia Pharma INC | $153.96 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $142.98 | 2020-2021 | |
| Tersera Therapeutics LLC | $126.66 | 2023-2025 | Prialt |
| Protega Pharmaceutials INC | $116.71 | 2022-2023 | Roxybond |
| Lilly USA, LLC | $102.92 | 2020-2021 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Haynes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.